Paraaortic lymph node metastasis in patients with intra-abdominal malignancies: CT vs PET by 김기황 et al.
www.wjgnet.com
 BRIEF ARTICLES
Paraaortic lymph node metastasis in patients with intra-
abdominal malignancies: CT vs  PET
Mi-Jung Lee, Mi Jin Yun, Mi-Suk Park, Seung Hwan Cha, Myeong-Jin Kim, Jong Doo Lee, Ki Whang Kim
Online Submissions: wjg.wjgnet.com                             World J Gastroenterol  2009 September 21; 15(35): 4434-4438
wjg@wjgnet.com                                                                                               World Journal of Gastroenterology  ISSN 1007-9327
doi:10.3748/wjg.15.4434                                                                                          © 2009 The WJG Press and Baishideng. All rights reserved.
Mi-Jung Lee, Mi-Suk Park, Seung Hwan Cha, Myeong-Jin 
Kim, Ki Whang Kim, Department of Diagnostic Radiology, 
Research Institute of Radiological Science, and Institute of 
Gastroenterology, Yonsei University, College of Medicine, 134 
Sincheon-Dong Seodaemun-Gu, Seoul 120-752, South Korea
Mi Jin Yun, Jong Doo Lee, Department of Nuclear medicine, 
Yonsei University, College of Medicine, 134 Sincheon-Dong 
Seodaemun-Gu, Seoul 120-752, South Korea
Seung Hwan Cha, Department of Diagnostic Radiology, 
Yonsei University, Wonju College of Medicine, Wonju 220-701, 
South Korea
Author contributions: Lee MJ and Park MS designed the 
research; Lee MJ, Park MS and Cha SH reviewed the CT 
images; Yun MJ and Lee JD reviewed the PET images; Lee MJ 
and Park MS wrote the paper; Kim MJ and Kim KW edited this 
paper.
Correspondence to: Mi-Suk Park, MD, Department of 
Diagnostic Radiology and Research Institute of Radiological 
Science, Yonsei University College of Medicine, 134 Sincheon-
Dong Seodaemun-Gu, Seoul 120-752, 
South Korea. radpms@yuhs.ac
Telephone: +82-2-22287400  Fax: +82-2-3933035
Received: May 12, 2009        Revised: August 13, 2009
Accepted: August 20, 2009
Published online: September 21, 2009
Abstract
AIM: To compare the diagnostic accuracy of computed 
tomography (CT) and positron emission tomography 
(PET) for the preoperative detection of paraaortic 
lymph node (PAN) metastasis in patients with intra-
abdominal malignancies. 
METHODS: Sixty-six patients with intra-abdominal 
malignancies who underwent both CT and PET 
before lymphadenectomy were included in this study. 
Histopathologically, 13 patients had metastatic PAN, 
while 53 had non-metastatic PAN. The CT criteria for 
metastasis were: short diameter of > 8 mm, lobular 
or irregular shape, and/or combined ancillary findings, 
including necrosis, conglomeration, vessel encasement, 
and infiltration. The PET criterion was positive 
fluorodeoxyglucose (FDG) uptake. The sensitivity, 
specificity, positive predictive value (PPV), negative 
predictive value (NPV), and accuracy of both modalities 
were compared with the pathologic findings, and the 
false positive and false negative cases with both CT 
and PET were analyzed.
RESULTS: The sensitivity, specificity, PPV, NPV, and 
accuracy of CT were 61.5%, 84.9%, 50%, 90% and 
80.3%, respectively. For PET, the percentages were 
46.2%, 100%, 100%, 88.3%, and 89.4%. Additionally, 
there were 8 false positive CT cases (8/53, 15.1%) 
and zero false positive PET cases. Of the 13 metastatic 
PANs, there were 5 false negative CT scans (38.5%) 
and 7 (53.9%) false negative PET scans.
CONCLUSION: For detecting PAN metastasis, CT is 
more sensitive than PET, while PET is more specific. 
© 2009 The WJG Press and Baishideng. All rights reserved.
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INTRODUCTION
Paraaortic lymph node (PAN) metastasis is considered 
an important prognostic factor in several abdominal and 
pelvic malignancies, such as stomach cancer, colorectal 
cancer, cholangiocarcinoma, and cervical cancer[1-4]. 
While it is very important to evaluate PAN metastasis 
in preoperative evaluations, the correct diagnosis is not 
always definitively determined. Because of  this, sampling 
and pathologic confirmation of  the paraaortic nodes 
should be carried out before starting a radical operation, 
which is why many surgeons, including those in our 
hospital, perform paraaortic node dissection before 
radical surgery[5-8]. Although lymphadenectomy followed 
by histologic examination of  the lymph nodes is still 
the gold standard for determining metastasis, doctors 
must be careful in using this technique because of  the 
perioperative risks and postoperative complications of  
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PAN dissection[3,9,10]. All of  this makes preoperative, 
noninvasive imaging diagnosis of  PAN metastasis very 
important[11,12].
For  preopera t ive  eva lua t ion  of  abdomina l 
malignancies, computed tomography (CT) has usually 
been used as the first-line examination. However, many 
investigators have reported CT to have low sensitivity 
and low specificity when used for lymph node (LN) 
diagnosis. Nowadays, positron emission tomography 
(PET) with f luorodeoxyglucose (FDG) has been 
recognized as a useful diagnostic technique in clinical 
oncology, not only for primary tumor evaluation, 
but also for detection of  metastasis (including nodal 
metastasis)[13]. However, FDG-PET has also been 
reported to have low sensitivity for the detection of  
LN metastasis[14], and FDG-PET cannot determine 
the anatomical location of  small lesions, such as lymph 
nodes[15]. To our knowledge, however, there has been 
limited study comparing CT with PET in evaluating 
PAN metastasis[16,17].
The purpose of  our study is to compare the 
diagnostic accuracy of  CT and FDG-PET in the 
preoperative detection of  PAN metastasis in patients 
with an intra-abdominal malignancy. We also analyze the 
false positive and false negative cases of  both CT and 




The protocol for this study was approved by the 
Institutional Review Board at our institution and 
informed consent was not required. Our pathologic 
database was retrospectively searched from September 
2002 to July 2006 for all patients who underwent 
paraaortic lymphadenectomy before or during a surgical 
resection operation. A total of  305 patients were selected 
from the database, and, among these, 113 had underlying 
intra-abdominal malignancies (excluding lymphoma). 
Finally, 66 patients (39 women and 27 men, age range 
28-78 years, mean age 56 years) who underwent both 
CT and PET no ≤ 1 mo before a lymph node biopsy 
were chosen for the study. The underlying malignancies 
were as follows: hepatobiliary cancer (n = 11), pancreatic 
cancer (n = 10), colorectal cancer (n = 20), gastric cancer 
(n = 3), cervical cancer (n = 7) and tubo-ovarian cancer 
(n = 15). 
Imaging procedures
For CT, all patients underwent single-section spiral 
CT (HiSpeed CT/I, GE Medical Systems, Milwaukee, 
WI) or multi-detector CT scanning (four detector row; 
Lightspeed Plus, GE Medical Systems, Milwaukee, WI or 
sixteen-detector row; Sensation 16, Siemens, Erlangen, 
Germany) according to an established protocol. A 
60% iodinated contrast material [Iopromide (Ultravist); 
Schering, Berlin, diatrizoate meglumine (Hypaque) 
or iohexol (Omnipaque 300); Nycomed Amersham, 
Princeton, NJ] was administered intravenously at a rate 
of  2-4 mL/s by using an automatic power injector with 
a volume of  2 mL/kg, up to a maximum volume of  
150 mL. Portal venous phase CT scans were obtained 
70 s after initiating the contrast material injection, and 
the abdomen and pelvis, from the level of  the hepatic 
dome to the ischial tuberosities, were scanned with 
a pitch of  1.0-1.5 and a reconstruction thickness of  
3.0-5.0 mm. The transverse images were reconstructed 
with a soft-tissue algorithm.
For PET, patients fasted at least 4 h before intravenous 
injection of  18F-FDG, and scanning began 60 min 
later. Images from the neck to the proximal thigh were 
obtained either on an Advance PET scanner (GE 
advance, GE Medical Systems, Milwaukee, WI), with 
a spatial resolution of  5 mm in the center of  the field 
of  view, or an Allegro PET scanner (Allegro, Philips-
ADAC medical systems, Cleveland, OH), with a spatial 
resolution of  5.3 mm in the center of  the field of  view. 
For the Advance scanner, approximately 370 MBq of  
18F-FDG were intravenously injected, and the emission 
scan was acquired for 5 min per bed position in the 
2-dimensional mode. The Allegro acquired data in the 
3-dimensional mode after administration of  5.18 MBq 
(0.14 mCi)/kg of  18F-FDG. Transmission scans (3 min 
per bed position) to correct for non-uniform attenuation 
were obtained using point sources of  68Ge for the 
Advance or 137Cs for the Allegro. Transmission scans 
were interleaved with the multiple emission scans for the 
Allegro. The images were reconstructed using an iterative 
reconstruction algorithm: that is, either the ordered-
subset expectation maximization for the Advance or the 
low-action maximal-likelihood algorithm for the Allegro. 
Imaging analysis
All imaging analysis was performed on a picture 
a rch iv ing  and communica t ion  sys tem (PACS) 
workstation (Centricity 1.0; GE Medical Systems). Two 
radiologists independently evaluated preoperative CT 
images in the 66 patients without knowledge of  the final 
pathologic diagnoses. They considered the following 
criteria as the primary findings for a metastatic PAN: 
short diameter > 8 mm, lobular or irregular shape, 
and/or combined ancillary findings including necrosis, 
conglomeration, vessel encasement, and infiltration 
(Figure 1). Reviewers characterized the PAN as 
metastatic or non-metastatic. When discrepancies were 
detected, interpretations were achieved via consensus. 
Two experienced nuclear medicine physicians also 
interpreted the preoperative PET images, where the 
criterion was positive FDG uptake. When discrepancies 
were detected, interpretations were determined via 
consensus. The sensitivity, specificity, positive predictive 
value (PPV), negative predictive value (NPV), and 
accuracy of  CT and PET for the detection of  metastatic 
PAN were then calculated.
As a second portion of  our study, a third radiologist 
analyzed the cases of  false diagnosis for both CT and 
PET scans. She also evaluated the relationship between 
primary tumors and PAN in terms of  the FDG uptake 
of  the primary tumors on PET.
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RESULTS
In our 66 patients, we found 13 patients with metastatic 
paraaortic nodes and 53 patients with non-metastatic 
ones according to the pathologic results. 
The sensitivity, specificity, PPV, NPV, and accuracy 
of  CT for detecting PAN metastasis were 61.5% (8/13), 
84.9% (45/53), 50% (8/16), 90% (45/50), and 80.3% 
(53/66), respectively. For PET, the results were 46.2% 
(6/13), 100% (53/53), 100% (6/6), 88.3% (53/60), and 
89.4% (59/66), respectively. From these numbers, we 
can conclude that CT was more sensitive while PET 
was more specific, and the overall accuracy was slightly 
higher with PET.
With CT, 8 (15.1%) of  the 53 non-metastatic nodes 
were false positively diagnosed (Figure 2). One of  these 
cases showed central necrosis. There were no false 
positives using PET, as all 53 showed no FDG uptake. 
For the 13 metastatic nodes, 5 cases (38.5%) on CT, 
7 cases (53.9%) on PET, and 4 cases (30.8%) on both 
CT and PET were false negatively diagnosed. Among 
the false negative CT cases, only one (1/5, 20%) showed 
positive FDG uptake on PET. Among the false negative 
PET cases, 3 (3/7, 42.9%) were diagnosed as malignant 
nodes on CT (Figure 3).
In terms of  the relationship between a primary tumor 
and PAN on FDG uptake, six of  the seven false negative 
metastatic PAN cases showed high FDG uptake on the 
primary tumor. Only one patient with primary stomach 
cancer with ovarian metastasis showed negative FDG 
uptake on both the metastatic PAN and the primary 
tumor. A total of  3 cases (3/66, 4.5%) showed no FDG 
uptake on the primary tumor, and one of  these (1/3, 33%) 
showed negative FDG uptake on the metastatic PAN.
DISCUSSION
Our study shows that CT is more sensitive than PET, 
while PET is more specific than CT for the diagnosis of  
metastatic PAN in patients with abdominal malignancies. 
PET has generally been considered a sensitive tool 
for detecting distant metastasis[13,18,19]. In daily practice, 
PET detects some lesions that are difficult to detect 
by CT, such as mesenteric or pelvic nodes between 
bowel loops. However, when considering only PAN, CT 
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Figure 1  Typical case of metastatic paraaortic lymph node (PAN) on both 
computed tomography (CT) and positron emission tomography (PET). A 
52-year-old woman with ovarian cancer underwent CT and PET. (A) Axial CT 
scan shows enlarged (short diameter was 16 mm) and conglomerated PAN (ar-
row) and (B) coronal view of PET image shows positive FDG uptake in this PAN 
(arrow).
A B
Figure 2  False positive metastatic PAN on CT. A 38-year-old man with colon 
cancer underwent CT and PET. (A) Coronal CT scan shows multiple enlarged 
(short diameter was 8 mm in the largest one) PAN (arrow), but (B) coronal 
view of PET image shows negative fluorodeoxyglucose uptake in these lymph 




Figure 3  False negative metastatic PAN on PET. A 72-year-old woman with 
common bile duct cancer underwent CT and PET. (A) Axial CT scan shows en-
larged (short diameter was 12 mm) PAN (arrow) with surrounding fat infiltration, 
but (B) coronal view of PET image shows negative FDG uptake in this lymph 
node. Pathology was confirmed as metastatic lymph node.
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showed more sensitivity than PET in our study.
PET is a functional imaging modality based on 
the increased glucose metabolism of  physiologic or 
pathologic conditions. Because of  this, PET has a 
limitation associated with metabolism: the primary 
tumor must have a strong avidity for 18F-FDG, 
which may or may not be the case, depending on the 
histopathologic type of  the tumor[14,20]. Low metabolic 
activity can cause a false negative PET scan[13], while 
a non-tumorous hypermetabolic condition, such as a 
systemic inflammation or an infection, can lead to false 
positive uptake[13]. The usefulness of  PET imaging is also 
limited in patients with uncontrolled diabetes mellitus 
(> 150 mg/dL)[14].
In our study, PET (53.9%) showed higher false 
negative rates than CT (38.5%) in metastatic PAN. 
One false negative metastatic PAN case (14.3%) also 
showed no FDG uptake on the primary tumor. The 
FDG activity of  the primary tumor may reflect that of  
the metastatic PAN, meaning more careful attention is 
required to diagnose PAN if  the primary tumor shows 
no FDG uptake.
Among the 7 false negative PET cases, 3 (42.9%) 
were diagnosed as metastatic PAN using CT because 
they showed necrosis or conglomeration, even though 
the short diameter was < 8 mm. This means that CT 
may be helpful in the characterization of  false negative 
PET cases.
CT also showed higher false positive rates than PET 
in our study. Many studies discuss the criteria for the 
detection of  metastatic lymph nodes on CT, with size as 
the most frequently used parameter[14,19,21-24]. However, 
this places a major limitation on CT, as it will be unable 
to detect small, metastatic lymph nodes and might 
misrepresent large, reactive lymph nodes[13,19]. All of  the 
false positive cases in our study showed no FDG uptake, 
which suggests that FDG-PET may be very useful for 
increasing the specificity of  CT.
Integrated PET-CT has been introduced into clinical 
practice, providing shorter total imaging time and a 
reduction in the number of  ambiguous lesions[25,26]. 
Moreover, some researchers have reported that PET-
CT improves diagnostic accuracy when compared with 
PET alone in abdominal and pelvic cancer[27]. Recent 
studies report the sensitivity, specificity, and accuracy of  
PET-CT for lymph node metastasis as 28.6%-51.7%, 
92.9%-99.8%, and 75.0%-99.8%, respectively[15,17,28], but 
this still shows the lower sensitivity and higher specificity 
of  PET-CT. While the role of  CT in PET-CT is 
usually limited to anatomic localization and attenuation 
correction[25], the results of  our study suggest that CT 
is useful not only for anatomic localization, but also for 
a reduction in the false negative rate of  PET. Previous 
studies have also reported that dedicated CT scans do 
additional work in some cases, such detecting as stomach 
cancer, liver cancer and mucinous primary or metastatic 
tumors[19,26,29]. Moreover, there are some reports about 
integrated PET/contrast-enhanced CT as an accurate 
modality for assessing colorectal cancer in recent 
studies[30,31]. However, the usefulness of  integrated PET/
contrast-enhanced CT in other malignancies is still being 
debating and additional study of  this topic is needed.
There are some limitations to our study. First, the 
diagnoses were variable with intra-abdominal malignancy 
(including hepatobiliary cancer, gastrointestinal cancer 
and gynecologic cancer) except lymphoma. Tumor 
characteristics on PET and lymphatic drainage pattern 
can be different between these malignancies. The second 
limitation is that we evaluated the data not on a per-
node basis, but on a per-case basis. This is a limitation 
of  retrospective study, and further evaluation with 
prospective study is needed.
In conclusion, CT is more sensitive than PET for 
detecting PAN metastasis, but PET is more specific. 
PET is useful for ruling out enlarged reactive lymph 
nodes and reducing the false positive rate of  CT scans 
alone. To reduce the false negative rate of  PET, CT can 
be helpful by showing necrosis or other ancillary findings 
of  PAN. These results all suggest that the two modalities 




Paraaortic lymph node (PAN) metastasis is considered an important prognostic 
factor in several abdominal and pelvic malignancies. However, the correct 
diagnosis is not always definitively determined. Pathologic confirmation 
before starting a radical operation has perioperative risks and postoperative 
complications. Therefore, preoperative, noninvasive imaging diagnosis of PAN 
metastasis is very important. 
Research frontiers
For preoperative evaluation of abdominal malignancies, computed tomography 
(CT) has usually been used as the first-line examination. Positron emission 
tomography (PET) with fluorodeoxyglucose (FDG) has been recognized as 
a useful diagnostic technique in clinical oncology. However, there has been 
limited study comparing CT with PET in evaluating PAN metastasis. The aim 
of our study is to compare the diagnostic accuracy of CT and FDG-PET in the 
preoperative detection of PAN metastasis in patients with an intra-abdominal 
malignancy. 
Innovations and breakthroughs
CT is more sensitive than PET for detecting PAN metastasis, but PET is more 
specific. PET is useful for ruling out enlarged reactive lymph nodes and reducing 
the false positive rate of CT scans alone. To reduce the false negative rate of PET, 
CT can be helpful by showing necrosis or other ancillary findings of PAN. 
Applications
CT and PET are complementary to each other in the diagnosis of PAN 
metastasis in patients with an intra-abdominal malignancy. 
Peer review
Preoperative evaluation of paraaortic lymph node metastasis is very important 
in intra-abdominal malignancy. The results of this study are interesting as a 
preliminary result. It may be a first step to confirm the results of a prospective 
study in the future.
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